The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces differentiation of human breast cancer cells.

被引：0
|
作者：
Munster, PN
Rosen, N
Rifkind, R
Marks, P
Richon, V
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
356
引用
收藏
页码：3725S / 3725S
页数：1
相关论文
共 50 条
  • [31] Histone Deacetylase Inhibitor (HDACi) Suberoylanilide Hydroxamic Acid (SAHA)-mediated Correction of α1-Antitrypsin Deficiency
    Bouchecareilh, Marion
    Hutt, Darren M.
    Szajner, Patricia
    Flotte, Terence R.
    Balch, William E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (45)
  • [32] The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes
    Bocchi, Leonardo
    Motta, Benedetta M.
    Savi, Monia
    Vilella, Rocchina
    Meraviglia, Viviana
    Rizzi, Federica
    Galati, Serena
    Buschini, Annamaria
    Lazzaretti, Mirca
    Pramstaller, Peter P.
    Rossini, Alessandra
    Stilli, Donatella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (08)
  • [33] Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors
    Cohen, LA
    Marks, PA
    Rifkind, RA
    Amin, S
    Desai, D
    Pittman, B
    Richon, VM
    ANTICANCER RESEARCH, 2002, 22 (03) : 1497 - 1504
  • [34] The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Confers Acute Neuroprotection After Intracerebral Hemorrhage in Mice
    Sukumari-Ramesh, Sangeetha
    Alleyne, Cargill H., Jr.
    Dhandapani, Krishnan M.
    TRANSLATIONAL STROKE RESEARCH, 2016, 7 (02) : 141 - 148
  • [35] Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
    Butler, LM
    Agus, DB
    Scher, HI
    Higgins, B
    Rose, A
    Cordon-Cardo, C
    Thaler, HT
    Rifkind, RA
    Marks, PA
    Richon, VM
    CANCER RESEARCH, 2000, 60 (18) : 5165 - 5170
  • [36] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, improved radiosensitivity of human hepatocellular carcinoma
    Chen, Fang-Hsin
    Yu, Ching-Fang
    Hong, Ji-Hong
    CANCER RESEARCH, 2017, 77
  • [37] The mechanism of Histone deacetylase inhibitor (Suberoylanilide hydroxamic acid) suppresses pancreatic cancer in vitro
    Yang, Bo
    Li, Shengze
    Zhou, Quansheng
    Cao, Cong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S44 - S44
  • [38] The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces growth arrest and apoptosis in multiple myeloma (MM) and Waldenstrom's macroglobulinemia (WM) cell lines and patient tumor cells.
    Mitsiades, N
    Mitsiades, CS
    Poulaki, V
    Anderson, KC
    Treon, SP
    BLOOD, 2001, 98 (11) : 376A - 376A
  • [39] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
    Shi, Yi-kang
    Li, Zhong-hua
    Han, Xi-qian
    Yi, Ji-hu
    Wang, Zhen-hua
    Hou, Jing-li
    Feng, Cong-ran
    Fang, Qing-hong
    Wang, Hui-hui
    Zhang, Peng-fei
    Wang, Feng-shan
    Shen, Jie
    Wang, Peng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (06) : 1131 - 1140
  • [40] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
    Yi-kang Shi
    Zhong-hua Li
    Xi-qian Han
    Ji-hu Yi
    Zhen-hua Wang
    Jing-li Hou
    Cong-ran Feng
    Qing-hong Fang
    Hui-hui Wang
    Peng-fei Zhang
    Feng-shan Wang
    Jie Shen
    Peng Wang
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 1131 - 1140
12345